- Home
- CRT vs NTRB Comparison
CRT vs NTRB Comparison
Compare CRT & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRT
- NTRB
- Stock Information
- Founded
- CRT 1991
- NTRB 2016
- Country
- CRT United States
- NTRB United States
- Employees
- CRT N/A
- NTRB N/A
- Industry
- CRT Oil & Gas Production
- NTRB Industrial Specialties
- Sector
- CRT Energy
- NTRB Health Care
- Exchange
- CRT Nasdaq
- NTRB Nasdaq
- Market Cap
- CRT 65.1M
- NTRB 59.1M
- IPO Year
- CRT 1992
- NTRB N/A
- Fundamental
- Price
- CRT $9.78
- NTRB $8.10
- Analyst Decision
- CRT
- NTRB Buy
- Analyst Count
- CRT 0
- NTRB 1
- Target Price
- CRT N/A
- NTRB $13.00
- AVG Volume (30 Days)
- CRT 24.7K
- NTRB 78.1K
- Earning Date
- CRT 01-01-0001
- NTRB 05-30-2025
- Dividend Yield
- CRT 9.01%
- NTRB N/A
- EPS Growth
- CRT N/A
- NTRB N/A
- EPS
- CRT 0.99
- NTRB N/A
- Revenue
- CRT $6,834,116.00
- NTRB $2,398,437.00
- Revenue This Year
- CRT N/A
- NTRB $560.75
- Revenue Next Year
- CRT N/A
- NTRB $588.39
- P/E Ratio
- CRT $9.89
- NTRB N/A
- Revenue Growth
- CRT N/A
- NTRB 18.92
- 52 Week Low
- CRT $8.88
- NTRB $3.72
- 52 Week High
- CRT $13.31
- NTRB $11.78
- Technical
- Relative Strength Index (RSI)
- CRT 43.47
- NTRB 62.62
- Support Level
- CRT $9.66
- NTRB $7.52
- Resistance Level
- CRT $9.88
- NTRB $7.80
- Average True Range (ATR)
- CRT 0.17
- NTRB 0.45
- MACD
- CRT 0.00
- NTRB -0.03
- Stochastic Oscillator
- CRT 16.44
- NTRB 69.46
About CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.